Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (9)

2018

  1. Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes

    European Journal of Haematology, Vol. 101, Núm. 3, pp. 332-339

2017

  1. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML

    Bone Marrow Transplantation, Vol. 52, Núm. 8, pp. 1138-1143

  2. Single umbilical cord blood with or without CD341 cells from a third-party donor in adults with leukemia

    Blood Advances, Vol. 1, Núm. 15, pp. 1047-1055

2016

  1. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins

    Leukemia, Vol. 30, Núm. 4, pp. 861-872

2014

  1. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders

    Biology of Blood and Marrow Transplantation, Vol. 20, Núm. 12, pp. 2015-2022

1998

  1. Conventional cytogenetics and FISH evaluation of chimerism after sex- mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI)

    Haematologica, Vol. 83, Núm. 5, pp. 408-415

1997

  1. Dynamics of Sau3A in situ digestion of human chromosomes analyzed with computerized imaging

    Genome, Vol. 40, Núm. 1, pp. 123-126

1996

  1. Improving chimaerism quantification in bone marrow transplant recipients by image processing and analysis after restriction endonuclease in situ digestion (IPA-REISD)

    Leukemia, Vol. 10, Núm. 7, pp. 1232-1236

  2. Restriction endonuclease in situ digestion (REISD) and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation

    Cancer Genetics and Cytogenetics, Vol. 89, Núm. 2, pp. 141-145